Antiplatelet Agents Added to Aspirin: No Benefit for SVG Patency After CABG

Steven Goldman

doi:10.1161/CIRCULATIONAHA.120.050879

Antiplatelet Agents Added to Aspirin: No Benefit for SVG Patency After CABG

Steven Goldman

Medicine

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1808-1809
Number of pages	2
Journal	Circulation
Volume	142
Issue number	19
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.120.050879
State	Published - Nov 10 2020

Keywords

Editorials
aspirin
platelet aggregation inhibitors
ticagrelor

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1161/CIRCULATIONAHA.120.050879

Cite this

@article{ce7e15acb1d04414a56c6a74e5ca0402,

title = "Antiplatelet Agents Added to Aspirin: No Benefit for SVG Patency After CABG",

keywords = "Editorials, aspirin, platelet aggregation inhibitors, ticagrelor",

author = "Steven Goldman",

year = "2020",

month = nov,

day = "10",

doi = "10.1161/CIRCULATIONAHA.120.050879",

language = "English (US)",

volume = "142",

pages = "1808--1809",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "19",

}

TY - JOUR

T1 - Antiplatelet Agents Added to Aspirin

T2 - No Benefit for SVG Patency After CABG

AU - Goldman, Steven

PY - 2020/11/10

Y1 - 2020/11/10

KW - Editorials

KW - aspirin

KW - platelet aggregation inhibitors

KW - ticagrelor

UR - http://www.scopus.com/inward/record.url?scp=85095974366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85095974366&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.120.050879

DO - 10.1161/CIRCULATIONAHA.120.050879

M3 - Editorial

C2 - 32862720

SN - 0009-7322

VL - 142

SP - 1808

EP - 1809

JO - Circulation

JF - Circulation

IS - 19

ER -

Antiplatelet Agents Added to Aspirin: No Benefit for SVG Patency After CABG

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this